Business description: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Number of employees: 3,890

Sales by Activity: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Fiscal Period: December 2021 (CNY) 2022 (CNY) 2023 (CNY) 2024 (CNY) 2025 (CNY)

Western Medicine

1.6B 1.78B 1.7B 1.19B -

Others

627M 796M 673M 443M -

Chinese Patent Medicine

4.67B 5.65B 5.84B 5.66B -

Geographical breakdown of sales: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Fiscal Period: December 2021 (CNY) 2022 (CNY) 2023 (CNY) 2024 (CNY) 2025 (CNY)

Overseas

33.91M 33.74M 44.88M 36.73M -

China

6.86B 8.2B 8.16B 7.26B -

Executive Committee: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Manager TitleAgeSince
Director of Finance/CFO 48 2023-07-20
Chief Tech/Sci/R&D Officer 56 2017-10-09
Investor Relations Contact - -
Investor Relations Contact 50 -

Composition of the Board of Directors: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Director TitleAgeSince
Director/Board Member 65 2023-11-27
Director/Board Member 70 2020-06-04
Director/Board Member 56 2012-11-30
Director/Board Member 55 2021-12-09
Chairman 55 2024-11-25
Director/Board Member 39 2024-05-14
Director/Board Member 55 2021-09-05
Director/Board Member 52 2022-12-29
Director/Board Member 57 2023-06-20

Shareholders: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

NameEquities%Valuation
Jinhushen Biomedical Technology Co., Ltd.
58.4 %
331,202,728 58.4 % 1 961 M ¥
1.76 %
9,982,715 1.76 % 59 M ¥
China Southern Asset Management Co., Ltd.
0.7474 %
4,238,650 0.7474 % 25 M ¥
Fullgoal Fund Management Co., Ltd.
0.3032 %
1,719,558 0.3032 % 10 M ¥
Penghua Fund Management Co., Ltd.
0.1823 %
1,033,899 0.1823 % 6 M ¥
NameEquities%Valuation
Phillip Capital Management (S) Ltd.
0.0787 %
157,400 0.0787 % 508 402 ¥

Company details: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

Da Ren Tang Mansion

300193, Tianjin

+

http://www.jydrt.com.cn
address Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(600329)

Alternative Medicine

Change 5d. change 1-year change 3-years change Capi.($)
-1.09%-1.02%+35.35%+1.83% 4.06B
-0.41%+0.67%-3.76%-0.32% 14.47B
-0.75%-0.25%-23.21%-49.58% 5.58B
-2.88%-1.33%-13.55%+4.89% 5.09B
-2.74%-0.30%+26.54%-45.71% 4.09B
-1.35%-0.92%-4.74%-22.57% 3.37B
-1.18%+0.78%-5.06%-8.12% 3.12B
-1.07%-0.12%+14.71%-18.19% 2.58B
-0.60%-0.13%-3.28%-12.14% 1.95B
-0.75%-2.77%-7.58%+34.01% 1.74B
Average -1.28%+0.79%+1.54%-11.59% 4.6B
Weighted average by Cap. -1.17%+0.78%-0.31%-11.92%
  1. Stock Market
  2. Equities
  3. 600329 Stock
  4. Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited